[Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group].
Röttinger
E M
EM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D002330:Carmustine / Q000008:administration & dosage / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D004806:Ependymoma / Q000188:drug therapy* / Q000401:mortality*; D005500:Follow-Up Studies; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use; D007223:Infant; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy* / Q000401:mortality*; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
D003561:Cytarabine; D011344:Procarbazine; D014750:Vincristine; D002330:Carmustine; D008775:Methylprednisolone; D006918:Hydroxyurea
Uberleben von Kindern mit primitiven neuroektodermalen Tumoren und malignen Ependymomen des Zentralnervensystems nach Behandlung mit acht Zytostatika an einem Tag. Ein Bericht der "Children's Cancer Group".